|
|||||
|
|
Interferon β‐1a reduces increased interleukin‐16 levels in multiple sclerosis patients |
|
| Authors: | S. Nischwitz H. Faber P. G. Sämann H. S. Domingues G. Krishnamoorthy M. Knop F. Müller‐Sarnowski A. Yassouridis F. Weber |
| Affiliation: | 1. RG Inflammatory Disorders of the CNS, Neurology, Max Planck Institute of Psychiatry, , Munich, Germany;2. RG Neuroimaging, Max Planck Institute of Psychiatry, , Munich, Germany;3. Max Planck Institute of Neurobiology, , Martinsried, Germany;4. Instituto de Biologia Molecular e Celular R. Campo Alegre, , Porto, Portugal;5. RG Biostatistics, Max Planck Institute of Psychiatry, , Munich, Germany |
| Abstract: | |
| Keywords: | experimental autoimmune encephalomyelitis interferon‐β interleukin‐16 multiple sclerosis Th17 cells treatment |